Virtual Medicinal Product (VMP)
-
Lansoprazole 30mg orodispersible tablets
Name Details
Current Name
Lansoprazole 30mg orodispersible tablets
|
Start Date
24-08-2005
|
End Date
|
Previous Name
Lansoprazole 30mg orodispersible gastro-resistant tablets
|
Start Date
19-06-2003
|
End Date
23-08-2005
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Orodispersible tablet
- Ontology Form/Route
- tabletdispersiblegastro-resistant.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A02BC03
BNF |
Current BNF
01030500
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
01030500
|
Start Date
02-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
4053511000001104 |
10-03-2003 |
|
VMP Ingredients
VMP ingredients table
Lansoprazole |
Based on Ingredient Substance |
|
30 mg |
|
Name
Lansoprazole
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
30
Strength and UOM (Dmr)
Parent Products
-
VTM
Lansoprazole
-
VMP
(Current) Lansoprazole 30mg orodispersible tab...
Virtual Medicinal Product Pack (VMPP) Information